[144] GoDaddy Inc SEC Filing

Rhea-AI Filing Summary

Teva Pharmaceutical Industries Ltd. (TEVA) has filed a Form 144 announcing the possible sale of 52,742 ordinary shares through Citigroup Global Markets on or about 01-Aug-2025. The shares carry an estimated aggregate market value of $799,437 and equal roughly 0.005 % of the 1.15 billion shares outstanding, indicating a very small portion of the company’s float. The seller—an unnamed insider—received the stock on 01-Aug-2022 via a restricted share-unit (RSU) award. No other sales have been reported in the past three months. A Form 144 is a notice, not a guarantee, but signals that the insider may execute the transaction on the NYSE under Rule 144. Given the modest size and compensation-related origin, market impact is expected to be minimal, though insider sales can be perceived as a slight negative sentiment indicator.

Positive

• None.

Negative

• Insider plans to sell 52,742 shares worth approximately $0.8 M, which can be viewed as a slight negative sentiment signal.

Insights

Financial Analyst

TL;DR: Very small insider sale (~$0.8 M, 0.005 % float); signal mildly negative but fundamentally immaterial.

The filing reveals an insider’s intent to sell 52,742 RSU-derived shares. With 1.15 Bn shares outstanding, the sale is de minimis, unlikely to influence liquidity or price dynamics. Because the stock was earned via compensation and the insider has made no recent sales, the move could reflect routine diversification rather than concern over fundamentals. Investors may note it as a marginally bearish sentiment cue, yet the absence of additional negative disclosures or large volume keeps the overall impact neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	956720.40	142488191	08/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2022	Restricted Stock	Issuer			2110	03/01/2022	Not Applicable
Common	02/18/2022	Performance Shares	Issuer			3890	02/18/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
AMANPAL BHUTANI 100 S. Mill Ave Suite 1600 Tempe AZ 85281	Common	07/02/2025	6000	1061560.80
AMANPAL BHUTANI 100 S. Mill Ave Suite 1600 Tempe AZ 85281	Common	06/03/2025	6932	1246435.29
AMANPAL BHUTANI 100 S. Mill Ave Suite 1600 Tempe AZ 85281	Common	06/02/2025	3000	546090.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many TEVA shares are being sold under this Form 144?

The insider intends to sell 52,742 ordinary shares.

What is the estimated market value of the proposed TEVA share sale?

The aggregate market value is approximately $799,437.

What percentage of TEVA’s outstanding shares does the sale represent?

Roughly 0.005 % of the 1.15 billion shares outstanding.

When were the shares originally acquired by the insider?

The shares were acquired on 01-Aug-2022 via a restricted share-unit award.

Which broker will handle the TEVA share sale and on which exchange?

The sale is to be executed through Citigroup Global Markets on the NYSE.